Correction: A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual: Comparison of response, remission, and suicidality (American Journal of Psychiatry (2017) 174 (640-648) DOI: 10.1176/appi.ajp.2017.16010034);A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual: Comparison of response, remission, and suicidality

American Journal of Psychiatry

Volumn 174, Issue 7, 2017, Pages 640-648

  Aaronson, Scott T ^a   Sears, Peter ^a   Ruvuna, Francis ^a   Bunker, Mark ^a   Conway, Charles R ^a   Dougherty, Darin D ^a   Reimherr, Frederick W ^a   Schwartz, Thomas L ^a   Zajecka, John M ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; STIMULUS RESPONSE; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE; VAGUS NERVE STIMULATION; BIPOLAR DISORDER; CHRONIC DISEASE; COMPARATIVE STUDY; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; ELECTROCONVULSIVE THERAPY; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; REGISTER; SUICIDAL IDEATION;

ADULT; BIPOLAR DISORDER; CHRONIC DISEASE; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; SUICIDAL IDEATION; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

EID: 85021708725     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2017.17040431     Document Type: Erratum

References (25)

1. ∗D report. Am J Psychiatry 2006; 163:1905-1917
2. ∗D: implications for clinical practice. Am J Psychiatry 2006; 163:28-40
3. ∗D: revising conventional wisdom. CNS Drugs 2009; 23:627-647
4. ∗D report. Am J Psychiatry 2006; 163:1161-1172
5. Agency for Healthcare Research and Quality (AHRQ): Non-pharmacologic Interventions for Treatment-Resistant Depression in Adults (Comparative Effectiveness Review Number 33). Rockville, Md, AHRQ, Sept 2011. https://effectivehealthcare.ahrq.gov/ehc/products/76/792/TRD-CER33-20111110.pdf
6. Rush AJ, George MS, Sackeim HA, et al.: Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 2000; 47:276-286
7. Rush AJ, Sackeim HA, Marangell LB, et al.: Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 2005; 58:355-363
8. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition. Washington, DC, American Psychiatric Association, Oct 2010
9. Aaronson ST, Carpenter LL, Conway CR, et al.: Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimulat 2013; 6:631-640
10. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC, US Department of Health, Education, and Welfare, 1976, pp. 218-222
11. Sheehan DV, Lecrubier Y, Sheehan KH, et al.: The Mini-International Neuropsychiatric Interview (MINI): the development and validation of astructured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(SUPPL. 20):22-33
12. Carmody TJ, Rush AJ, Bernstein I, et al.: The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures. Eur Neuropsychopharmacol 2006; 16:601-611
13. Trivedi MH, Rush AJ, Ibrahim HM, et al.: The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004; 34:73-82
14. Rush AJ, Trivedi MH, Ibrahim HM, et al.: The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54:573-583
15. Wisniewski SR, Rush AJ, Balasubramani GK, et al.: Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract 2006; 12:71-79
16. Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35:837-844
17. Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70:41-55
18. Sterne JA, White IR, Carlin JB, et al.: Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009; 338:b2393
19. Burzykowski T, Carpenter J, Coens C, et al.: Missing data: discussion points from the PSI missing data expert group. Pharm Stat 2010; 9: 288-297
20. Yan X, Lee S, Li N: Missing data handling methodsin medical device clinical trials. J Biopharm Stat 2009; 19:1085-1098
21. Campbell G, Pennello G, Yue L: Missing data in the regulation of medical devices. J Biopharm Stat 2011; 21:180-195
22. Dunner DL, Rush AJ, Russell JM, et al.: Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J Clin Psychiatry 2006; 67:688-695
23. Hollon SD, DeRubeis RJ, Fawcett J, et al.: Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: arandomized clinical trial. JAMA Psychiatry 2014; 71:1157-1164
24. Rutherford BR, Wager TD, Roose SP: Expectancy and the treatment of depression: a review of experimental methodology and effects on patient outcome. Curr Psychiatry Rev 2010; 6:1-10
25. Papakostas GI, Østergaard SD, Iovieno N: The nature of placebo response in clinical studies of major depressive disorder. J Clin Psychiatry 2015; 76:456-466